Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49


Primary cell-based phenotypic assays to pharmacologically and genetically study fibrotic diseases in vitro.

Weigle S, Martin E, Voegtle A, Wahl B, Schuler M.

J Biol Methods. 2019 Jun 3;6(2):e115. doi: 10.14440/jbm.2019.285. eCollection 2019.


Baseline health status and setting impacted Minimal Clinically Important Differences in COPD: an explorative study.

Alma H, de Jong C, Jelusic D, Wittmann M, Schuler M, Kollen BJ, Sanderman R, Kocks J, Schultz K, der Molen TV.

J Clin Epidemiol. 2019 Jul 27. pii: S0895-4356(18)30992-2. doi: 10.1016/j.jclinepi.2019.07.015. [Epub ahead of print]


Thresholds for clinically important deterioration versus improvement in COPD health status: results from a randomised controlled trial in pulmonary rehabilitation and an observational study during routine clinical practice.

Alma HJ, de Jong C, Jelusic D, Wittmann M, Schuler M, Sanderman R, Schultz K, Kocks J, van der Molen T.

BMJ Open. 2019 Jun 28;9(6):e025776. doi: 10.1136/bmjopen-2018-025776.


[Postoperative mobilization after total hip arthroplasty : Measured by Fitbit activity trackers].

Doppelbauer M, Schüler M, Sauter D.

Orthopade. 2019 Jun 27. doi: 10.1007/s00132-019-03768-9. [Epub ahead of print] German.


Pre-post changes in main outcomes of medical rehabilitation in Germany: protocol of a systematic review and meta-analysis of individual participant and aggregated data.

Schuler M, Murauer K, Stangl S, Grau A, Gabriel K, Podger L, Heuschmann PU, Faller H.

BMJ Open. 2019 Jun 1;9(5):e023826. doi: 10.1136/bmjopen-2018-023826.


Human lung fibroblast-to-myofibroblast transformation is not driven by an LDH5-dependent metabolic shift towards aerobic glycolysis.

Schruf E, Schroeder V, Kuttruff CA, Weigle S, Krell M, Benz M, Bretschneider T, Holweg A, Schuler M, Frick M, Nicklin P, Garnett JP, Sobotta MC.

Respir Res. 2019 May 9;20(1):87. doi: 10.1186/s12931-019-1058-2.


The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD.

Reijnders T, Schuler M, Wittmann M, Jelusic D, Troosters T, Janssens W, Stenzel NM, Schultz K, von Leupoldt A.

Respir Med. 2019 Jan;146:87-95. doi: 10.1016/j.rmed.2018.12.004. Epub 2018 Dec 13.


Implementing the German Model of Work-Related Medical Rehabilitation: Did the Delivered Dose of Work-Related Treatment Components Increase?

Bethge M, Markus M, Streibelt M, Gerlich C, Schuler M.

Arch Phys Med Rehabil. 2018 Dec;99(12):2465-2471. doi: 10.1016/j.apmr.2018.06.018. Epub 2018 Jul 7.


The Impact of Loneliness on Outcomes of Pulmonary Rehabilitation in Patients with COPD.

Reijnders T, Schuler M, Jelusic D, Troosters T, Janssens W, Schultz K, von Leupoldt A.

COPD. 2018 Oct;15(5):446-453. doi: 10.1080/15412555.2018.1471128. Epub 2018 Nov 7.


Including changes in dyspnea after inpatient rehabilitation improves prediction models of exacerbations in COPD.

Schuler M, Wittmann M, Faller H, Schultz K.

Respir Med. 2018 Aug;141:87-93. doi: 10.1016/j.rmed.2018.06.027. Epub 2018 Jun 30.


The interrelations among aspects of dyspnea and symptoms of depression in COPD patients - a network analysis.

Schuler M, Wittmann M, Faller H, Schultz K.

J Affect Disord. 2018 Nov;240:33-40. doi: 10.1016/j.jad.2018.07.021. Epub 2018 Jul 23.


[Patient perspective of the importance of asthma- and COPD-specific rehabilitation components: A secondary data analysis].

Lingner H, Schmidt K, Aumann-Suslin I, Wittmann M, Schuler M, Schultz K.

Z Evid Fortbild Qual Gesundhwes. 2018 Sep;135-136:41-49. doi: 10.1016/j.zefq.2018.03.008. Epub 2018 Apr 26. German.


Assessment of depression before and after inpatient rehabilitation in COPD patients: Psychometric properties of the German version of the Patient Health Questionnaire (PHQ-9/PHQ-2).

Schuler M, Strohmayer M, Mühlig S, Schwaighofer B, Wittmann M, Faller H, Schultz K.

J Affect Disord. 2018 May;232:268-275. doi: 10.1016/j.jad.2018.02.037. Epub 2018 Feb 21.


Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial.

Schultz K, Jelusic D, Wittmann M, Krämer B, Huber V, Fuchs S, Lehbert N, Wingart S, Stojanovic D, Göhl O, Alma HJ, de Jong C, van der Molen T, Faller H, Schuler M.

Eur Respir J. 2018 Jan 25;51(1). pii: 1702000. doi: 10.1183/13993003.02000-2017. Print 2018 Jan.


Short Questionnaire for Workplace Analysis (KFZA): factorial validation in physicians and nurses working in hospital settings.

Appel P, Schuler M, Vogel H, Oezelsel A, Faller H.

J Occup Med Toxicol. 2017 May 12;12:11. doi: 10.1186/s12995-017-0157-6. eCollection 2017.


Screening for symptom burden and supportive needs of patients with glioblastoma and brain metastases and their caregivers in relation to their use of specialized palliative care.

Seekatz B, Lukasczik M, Löhr M, Ehrmann K, Schuler M, Keßler AF, Neuderth S, Ernestus RI, van Oorschot B.

Support Care Cancer. 2017 Sep;25(9):2761-2770. doi: 10.1007/s00520-017-3687-7. Epub 2017 Mar 29.


Effectiveness of pulmonary rehabilitation for patients with asthma: study protocol of a randomized controlled trial (EPRA).

Schultz K, Seidl H, Jelusic D, Wagner R, Wittmann M, Faller H, Nowak D, Schuler M.

BMC Pulm Med. 2017 Mar 9;17(1):49. doi: 10.1186/s12890-017-0389-3.


Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis.

Aumiller V, Strobel B, Romeike M, Schuler M, Stierstorfer BE, Kreuz S.

Sci Rep. 2017 Mar 10;7(1):149. doi: 10.1038/s41598-017-00270-0.


A multicentre validation of the 1-min sit-to-stand test in patients with COPD.

Crook S, Büsching G, Schultz K, Lehbert N, Jelusic D, Keusch S, Wittmann M, Schuler M, Radtke T, Frey M, Turk A, Puhan MA, Frei A.

Eur Respir J. 2017 Mar 2;49(3). pii: 1601871. doi: 10.1183/13993003.01871-2016. Print 2017 Mar.


Supplemental Content

Loading ...
Support Center